Central Venous Pressure Value Can Assist in Adjusting Norepinephrine Dosage After the Initial Resuscitation of Septic Shock
Sepsis and septic shock remain critical conditions associated with high morbidity and mortality worldwide. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) have redefined sepsis as a life-threatening organ dysfunction caused by a dysregulated host response to infection. Septic shock is characterized by persistent hypotension requiring vasopressors to maintain a mean arterial pressure (MAP) of at least 65 mmHg and elevated lactate levels, indicating tissue hypoperfusion. Despite these definitions, the optimal strategy for adjusting vasopressor dosage, particularly norepinephrine (NE), after initial resuscitation remains unclear. This study aimed to explore the relationship between central venous pressure (CVP), MAP, and lactate clearance to guide NE dosage adjustments in septic shock patients.
The study was conducted as a retrospective observational analysis in a 15-bed mixed intensive care unit (ICU) of a tertiary care university hospital. Patients diagnosed with septic shock according to Sepsis-3 criteria were included if they received at least 30 mL/kg of intravenous crystalloid fluid within 3 hours of diagnosis and achieved a MAP of 65 mmHg or higher, requiring NE. Patients were excluded if they underwent fluid challenges, changes in inotropes dosage or type, transfused blood products, or changes in mechanical ventilation strategy between the study intervals. Data were collected from the electronic patient monitoring system and hospital administration database.
The study divided patients into two groups based on whether their NE dosage was increased or decreased. Hemodynamic and tissue perfusion parameters were collected before (T1) and after (T2) adjusting the NE dosage, with the interval between T1 and T2 being less than 6 hours. Key parameters included heart rate (HR), blood pressure, CVP, arterial and central venous blood gas analysis, and lactate levels. The study also calculated the central venous-to-arterial carbon dioxide difference (Pcv-aCO2) and the ratio of P(v-a)CO2 to C(a-v)O2.
The results showed that in both the NE dosage increase and decrease groups, CVP and the pressure difference between the patient’s usual MAP and the current MAP (dMAP) at T1 were associated with lactate clearance. Specifically, in groups with low CVP (0 mmHg) (LC HM) and high CVP (≥10 mmHg) and high dMAP (>0 mmHg) (HC HM), a decrease in NE dosage led to a reduction in lactate levels. Conversely, in the group with high CVP (≥10 mmHg) and low dMAP (≤0 mmHg) (HC LM), both increasing and decreasing NE dosage resulted in elevated lactate levels, with the increase being more severe in the NE dosage increase group.
The study highlighted the importance of considering both CVP and MAP when adjusting NE dosage in septic shock patients after initial resuscitation. CVP serves as a surrogate for volume status and right ventricular function, while MAP reflects systemic vascular resistance and perfusion pressure. The findings suggest that in patients with low CVP and high MAP, reducing NE dosage can improve tissue perfusion, as indicated by lactate clearance. However, in patients with high CVP and low MAP, increasing NE dosage may exacerbate tissue hypoperfusion, leading to elevated lactate levels.
The study also emphasized the role of individualized targets in septic shock management. While the Surviving Sepsis Campaign guidelines recommend a MAP target of 65 mmHg, this study suggests that the patient’s usual MAP should be considered when setting individualized targets. This approach is particularly relevant for patients with chronic hypertension, who may require higher MAP levels to maintain adequate perfusion.
In addition to CVP and MAP, the study examined other tissue perfusion parameters, including pulse pulsation index, arterial pH, central venous oxygen saturation (ScvO2), and standard base excess (SBE). These parameters were found to have varying degrees of correlation with lactate clearance, further supporting the need for a comprehensive assessment of tissue perfusion when adjusting NE dosage.
The study’s findings have important implications for clinical practice. By incorporating CVP and MAP into the decision-making process, clinicians can make more informed choices regarding NE dosage adjustments in septic shock patients. This approach may help optimize tissue perfusion, reduce lactate levels, and improve patient outcomes. However, the study also acknowledged the limitations of its retrospective design and the need for prospective studies to validate these findings.
In conclusion, this study provides valuable insights into the hemodynamic management of septic shock patients after initial resuscitation. The combination of CVP and MAP can serve as a useful guide for adjusting NE dosage, with the goal of improving tissue perfusion and reducing lactate levels. By considering these parameters, clinicians can tailor their treatment strategies to the individual needs of each patient, potentially improving outcomes in this critically ill population.
doi.org/10.1097/CM9.0000000000000238
Was this helpful?
0 / 0